Jane Buchan - Jun 11, 2024 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Jane Buchan
Stock symbol
IMMX
Transactions as of
Jun 11, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 05:45 PM
Previous filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding IMMX Common Stock 22.5K Jun 11, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Option (Right to Buy) Award $0 +33K $0.00 33K Jun 11, 2024 Common Stock 33K $2.04 Direct F1

Explanation of Responses:

Id Content
F1 The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Remarks:

See Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the Reporting Person on December 15, 2021.